Bloomberg Television
Bloomberg Television
@markets·3.2M subscribers·94K videos

Obesity Drugs: When Can Patients Stop Taking Them?

Posted

June 30, 2023

Views

1,687

Likes

15

Comments

7

Engagement

1.30%

Search the Record

Indexed

Every word spoken in this episode is indexed. Type any phrase to jump straight to the moment it was said.

Type any word or phrase that may have been spoken. Click a result to seek the player to that exact moment.

Try a name, a topic, or a quoted line

YouTube Description

as posted by the channel

Two years and more than a million prescriptions after Wegovy first went on sale, there’s one taboo question for some doctors who prescribe Novo Nordisk A/S's hit obesity drug: When can patients stop taking it? Bloomberg's Naomi Kresge explains. #obesity #wegovy #wegovyweightloss #weightloss #weightlossjourney #weight #bloomberg

Read more about this story on bloomberg.com

--------

Follow Bloomberg for business news & analysis, uptotheminute market data, features, profiles and more

Connect with us on...

Guests & Subjects Covered

Obesity DrugsNovo Nordisk AS'sBloomberg's Naomi KresgeFollow BloombergTwitter Facebook Instagram

Sentinel Indexing in Progress

Metadata and chapters are available. Claim extraction for this episode is pending.

All video content is delivered via YouTube embedded players in accordance with the YouTube Terms of Service. Sentinel provides research tools that promote discovery and accountability across political media.

Obesity Drugs: When Can Patients Stop Taking Them? · Bloomberg Television · Sentinel